Vitamin D is Related to Markers of Vulnerable Plaque in Acute Myocardial Infarction

Vitamin D is a fat soluble vitamin involved in calcium and bone metabolism; recently its deficiency has been related to cardiovascular disease. In cardiac tissue, vitamin D suppresses metalloproteinases (MMPs) expression, enzymes directly associated with vulnerable plaque. To investigate whether the...

Full description

Saved in:
Bibliographic Details
Published inCurrent vascular pharmacology Vol. 16; no. 4; p. 355
Main Authors Machulsky, Nahuel Fernandez, Barchuk, Magali, Gagliardi, Juan, Gonzalez, Diego, Lombardo, Micaela, Escudero, Alejandro Garcia, Gigena, Gerardo, Blanco, Federico, Schreier, Laura, Fabre, Bibiana, Berg, Gabriela
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.01.2018
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Vitamin D is a fat soluble vitamin involved in calcium and bone metabolism; recently its deficiency has been related to cardiovascular disease. In cardiac tissue, vitamin D suppresses metalloproteinases (MMPs) expression, enzymes directly associated with vulnerable plaque. To investigate whether the association between vitamin D and leptin is related to markers of vulnerable plaque, such as MMPs in patients with acute myocardial infarction. We studied 66 male patients with acute myocardial infarction, undergoing primary angioplasty. Blood samples were obtained at admission and 24hs after the surgery. Leptin and vitamin D concentrations in serum and MMP-2 and -9 activities in plasma were determined. MMP-2 activity was increased in Vitamin D deficient/insufficient patients at admission (p=0.04) and 24 hs later (p=0.05). In a linear regression model, vitamin D explained 24% of the variance of MMP-2 activity (F=2.839 p=0.04). At admission, vitamin D correlated with serum leptin (r=-0.302 p=0.033), and explained 39.5% of its variation (F=4.432 p=0.003). In the studied population, vitamin D was inversely related to MMP-2 and leptin which are involved in coronary artery disease and acute myocardial infarction. The decrease in this hormone levels would be associated with a worse metabolic profile in acute coronary syndrome patients.
ISSN:1875-6212
DOI:10.2174/1570161115666170609102506